# Alpha Win Capital

> Alpha Win Capital is a VC fund backing Biotechnology and Biopharma. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Sheung Wan, Hong Kong
- Total investments: 2
- Last investment: Nov 2021
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.awc-hk.com

Alpha Win Capital is a company that deals in securities, advising on securities, and asset management.The company is engaged in various types of securities brokerage businesses, including securities brokerage, primary market underwriting, and placement, secondary market securities trading, and bonds, which are all regulated by SFC.It wasfounded in Sheung Wan, Hong Kong.

## Contacts

5 contacts available for Alpha Win Capital. Shizune tracks 1 team members at Alpha Win Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/alpha-win-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Medical Device | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series D | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Peak Wang | Founder, Partner & Managing Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Treadwell Therapeutics | Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer. Founded by a cadre of pre-eminent scientific luminaries, including Dr. Tak W. Mak, the Company's robust, internally developed pipeline includes a first-in-class PLK4 kinase inhibitor, CFI-400945, and abest-in-class TTK inhibitor, CFI-402257, and CFI-402411, an oral immunomodulatory kinase inhibitor with activity toward HPK1. Treadwell also has a robust pre-clinical pipeline with multiple biologic and next-generation TCR-based autologous cell therapy programs. | $91M | Series B | Nov 18, 2021 |  |
| Sirnaomics | Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology. | $105M | Series D | Oct 23, 2020 |  |

2 of 2 investments shown.

## Co-investors
- 3W Fund Management — VC Fund, 1 deal together
- Fortune Ocean Growth Fund — VC Fund, 1 deal together
- Hongtao Capital — VC Fund, 1 deal together
- [Longmen Capital](https://shizune.co/investors/profile/longmen-capital) — VC Fund, 1 deal together
- Prosperous Alliance Investments — VC Fund, 1 deal together
- [RiverHead Capital](https://shizune.co/investors/profile/river-head-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Alpha Win Capital invest in?

Alpha Win Capital invests primarily in Biotechnology, Biopharma and Health Care startups, most often at Series B and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Alpha Win Capital?

Public channels for Alpha Win Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Alpha Win Capital?

The team at Alpha Win Capital includes Peak Wang (Founder, Partner & Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co